Arş. Gör. Fehmi HİNDİLERDEN

Yayın Ağı

Makaleler 17

1. Emerging Survival Predictor Model in Essential Thrombocythemia: The AAA+ Model

Sönmez Ö., Oyur E., Yönal Hindilerden İ., Hindilerden F., SÖNMEZ M., Karışmaz A., et al.

American Journal of Hematology , cilt.101, sa.4, ss.880-883, 2026 (SCI-Expanded, Scopus)

2. A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond

Sönmez Ö., Oyur E., Yönal Hindilerden İ., Hindilerden F., SÖNMEZ M., Karışmaz A., et al.

Blood Advances , cilt.10, sa.4, ss.1250-1259, 2026 (SCI-Expanded, Scopus)

3. The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia

Akboga F., Hindilerden F., Hindilerden I. Y., Gulturk E., DENİZ G., GELMEZ M. Y.

Immunologic Research , cilt.73, sa.1, 2025 (SCI-Expanded, Scopus)

4. Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology

Baysal M., Aksoy E., Bedir K. H., ÖZMEN İBİŞ D., Patır P., Demirci U., et al.

Journal of Thrombosis and Thrombolysis , cilt.58, sa.2, ss.284-298, 2025 (SCI-Expanded, Scopus)

5. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

Sadri S., Yonal-Hindilerden I., mutlu Y. g., tiryaki t. o., Gemici A., Beköz H. S., et al.

The European Research Journal , cilt.9, sa.6, ss.1368-1379, 2023 (TRDizin)

6. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores İleri Yaştaki İmmün Trombotik Trombositopenik Purpura Hastalarında; PLASMIC ve French Skorlamalarının Rolü

Baysal M., Hindilerden F., ÜMİT E. G., DEMİR A. M., Karadağ F. K., Saydam G., et al.

Turkish Journal of Hematology , cilt.40, sa.4, ss.251-257, 2023 (SCI-Expanded)

7. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Akpinar S., Dogu M. H., ÇELİK S., Ekinci O., Hindilerden I. Y., Dal M. S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.22, sa.3, ss.169-173, 2022 (SCI-Expanded)

8. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Ulu B. U., Dal M. S., Hindilerden I. Y., Akay O. M., MEHTAP Ö., Buyukkurt N., et al.

JOURNAL OF CHEMOTHERAPY , cilt.34, sa.3, ss.190-198, 2022 (SCI-Expanded, Scopus)

9. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

CİVRİZ BOZDAĞ S., CENGİZ SEVAL G., Hindilerden I. Y., Hindilerden F., ANDIÇ N., BAYDAR M., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.39, sa.1, ss.43-54, 2022 (SCI-Expanded, Scopus, TRDizin)

10. Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma

Yonal-Hindilerden I., Hindilerden F., Mastanzade M., Tiryaki T. O., Tasan-Yenigun S., BİLEN Y., et al.

FRONTIERS IN ONCOLOGY , cilt.11, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection

Hindilerden F., Hindilerden I. Y., Kucukkaya R. D.

BALKAN MEDICAL JOURNAL , cilt.38, sa.2, ss.141-142, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case

Hindilerden F., Yonal-Hindilerden I., Akar E., Kart-Yasar K.

THROMBOSIS RESEARCH , cilt.195, ss.136-138, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Sahin E., Yonal-Hindilerden I., Hindilerden F., Daglar-Aday A., Nalcaci M.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, 2020 (SCI-Expanded, Scopus)

14. The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Yonal-Hindilerden I., Sahin E., Hindilerden F., Daglar-Aday A., Nalcaci M.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, 2020 (SCI-Expanded, Scopus)

15. Immune Thrombocytopenia in a Very Elderly Patient With Covid-19

Hindilerden F., Yonal-Hindilerden I., Sevtap S., Kart-Yasar K.

FRONTIERS IN MEDICINE , cilt.7, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Severe Autoimmune Hemolytic Anemia in COVID-19 Infection, Safely Treated with Steroids

Hindilerden F., Yonal-Hindilerden I., Akar E., Yesilbag Z., Kart-Yasar K.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.12, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.

YONAL-HINDILERDEN I., Daglar-Aday A., HINDILERDEN F., AKADAM-TEKER B., YILMAZ C., NALCACI M., et al.

Journal of clinical medicine research , cilt.8, ss.29-39, 2016 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. A practical tool for predicting outcomes in essential thrombocythemia: Triple (or quadruple) a risk model

Sonmez O., Oyur E., Hindilerden I. Y., Hindilerden F., SÖNMEZ M., Karismaz A., et al.

67th Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 6 - 09 Aralık 2025, cilt.146, ss.3805-3806, (Özet Bildiri)

2. Outcome of mycophenolate mophetil treatment in patients with proliferative lupus nephritis.

ARTIM ESEN B., ÖZLÜK M. Y., KILIÇASLAN I., HİNDİLERDEN F., KAMALI S., GÜL A., et al.

The 19th International Congress on SLE, Vancouver, Kanada, 24 - 27 Haziran 2010, ss.169, (Tam Metin Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler